Evidence map›Paper›PMID 42620776›Full record

ArticleResearch and practice in thrombosis and haemostasis2026

A Rare Combination of von Willebrand Disease Type 2A and 2M: Diagnostic and Therapeutic Challenges - A case report.

Floor Derikx, Inge Merry, Dennis Willemsen, Erik Beckers, Yvonne Henskens, Floor Heubel-Moenen

Abstract readCase Reports
In one paragraph

Article in Research and practice in thrombosis and haemostasis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Floor DerikxDepartment of Internal Medicine-Hematology, Maastricht University Medical Center+, Maastricht, The Netherlands.
Inge MerryDepartment of Internal Medicine-Hematology, Maastricht University Medical Center+, Maastricht, The Netherlands.
Dennis WillemsenDepartment of Internal Medicine, Anna Ziekenhuis, Geldrop, The Netherlands.
Erik BeckersDepartment of Internal Medicine-Hematology, Maastricht University Medical Center+, Maastricht, The Netherlands.
Yvonne HenskensCentral Diagnostic Laboratory, Maastricht University Medical Centre+, Maastricht, The Netherlands.
Floor Heubel-MoenenDepartment of Internal Medicine-Hematology, Maastricht University Medical Center+, Maastricht, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Combined von Willebrand disease (VWD) type 2A/2M is a rare phenotype characterized by overlapping qualitative defects affecting both multimer structure and von Willebrand factor (VWF) function. Key Clinical Question: How can congenital VWD be distinguished from acquired von Willebrand syndrome (AVWS) when both conditions contribute to an abnormal laboratory phenotype? Clinical Approach: A 73-year-old man with a previous diagnosis of VWD type 2M presented with severe gastrointestinal bleeding and severe aortic stenosis. Repeat VWF analysis showed loss of high-molecular-weight multimers, consistent with AVWS secondary to shear stress. Treatment with recombinant VWF (Veyvondi) restored high-molecular-weight multimers and achieved hemostatic control. Following transcatheter aortic valve implantation, the abnormal multimer pattern persisted. Subsequent genetic testing identified a pathogenic Conclusion: This case demonstrates how AVWS may obscure an underlying congenital VWD phenotype. Combined phenotypic and molecular diagnostics are essential for accurate classification, therapeutic decision making, and interpretation of complex VWD phenotypes.

Indexed as

von Willebrand Disease, Type 2von Willebrand FactorAgedAortic Valve StenosisGastrointestinal HemorrhageHumansMalePhenotypeRecombinant ProteinsTranscatheter Aortic Valve ReplacementTreatment OutcomeRecombinant Proteinsvon Willebrand Factorbleeding disordersgenetic testinghemostasismultidisciplinary approachtype 2A/2Mvon Willebrand disease

Identifiers

PMID42620776
PMCPMC13485626

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.